Celyad Sa Stock Cash And Equivalents
Celyad SA fundamentals help investors to digest information that contributes to Celyad SA's financial success or failures. It also enables traders to predict the movement of Celyad Stock. The fundamental analysis module provides a way to measure Celyad SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celyad SA stock.
Celyad |
Celyad SA Company Cash And Equivalents Analysis
Celyad SA's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Celyad SA Cash And Equivalents | 14.38 M |
Most of Celyad SA's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celyad SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Celyad SA has 14.38 M in Cash And Equivalents. This is 98.25% lower than that of the Biotechnology sector and 96.78% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.47% higher than that of the company.
Celyad Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celyad SA's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celyad SA could also be used in its relative valuation, which is a method of valuing Celyad SA by comparing valuation metrics of similar companies.Celyad SA is currently under evaluation in cash and equivalents category among its peers.
Celyad Fundamentals
| Return On Equity | -1.71 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | (1.57 M) | |||
| Shares Outstanding | 22.59 M | |||
| Shares Owned By Institutions | 29.16 % | |||
| Number Of Shares Shorted | 130.17 K | |||
| Price To Earning | (22.08) X | |||
| Price To Book | 0.69 X | |||
| Price To Sales | 12,738 X | |||
| Gross Profit | 5 K | |||
| EBITDA | (18.81 M) | |||
| Net Income | (40.94 M) | |||
| Cash And Equivalents | 14.38 M | |||
| Cash Per Share | 0.64 X | |||
| Total Debt | 255 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 1.71 X | |||
| Book Value Per Share | 0.19 X | |||
| Cash Flow From Operations | (28.01 M) | |||
| Short Ratio | 11.46 X | |||
| Earnings Per Share | (1.47) X | |||
| Target Price | 8.52 | |||
| Number Of Employees | 35 | |||
| Beta | 1.69 | |||
| Market Capitalization | 14.24 M | |||
| Total Asset | 19.72 M | |||
| Retained Earnings | (349.95 M) | |||
| Working Capital | 4.4 M | |||
| Current Asset | 118.86 M | |||
| Current Liabilities | 12.48 M | |||
| Z Score | 5.77 | |||
| Net Asset | 19.72 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Celyad Stock
If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |